As the CBD movement continues to grow, we are very optimistic that both hemp-derived and marijuana-derived CBD will be completely legal in all 50 states within the next 5 years. Of course, it is still very hard to predict the future, especially given the constantly shifting political landscape, but we can continue to push forward, build awareness, and educate the world about the benefits of CBD.
In theory, getting a false positive on a drug test from CBD oil should be relatively impossible from pure CBD oil containing less than .3 percent THC. However, because CBD oil is not very well regulated, there is no guarantee that a product contains pure CBD oil, or that its concentration is at a safe or effective level. It is best to use utmost caution and do your research when purchasing a quality CBD oil product to ensure its purity, especially if you need to undergo drug screenings.
Hemp is a controversial crop in some regions of the world, due to concerns about psychoactive plants in the Cannabis genus. In some regions, cultivation of hemp is banned, although products made from hemp such as oil, hemp garments, and hemp paper may be legal. In other areas, hemp is permitted, but only industrial hemp, and some nations freely permit cultivation of all plants in this genus, assuming that regulation is a more efficient technique for control than outright bans. Wild hemp is also not uncommon in some regions of the world, making it difficult to enforce bans on hemp crops.
Acute effects may include anxiety and panic, impaired attention and memory, an increased risk of psychotic symptoms, [b] the inability to think clearly, and an increased risk of accidents.[68][69][70] Cannabis impaired a person's driving ability, and THC was the drug most frequently found in the blood of drivers who have been involved in vehicle crashes. Those with THC in their system were from three to seven times more likely to be the cause of the accident than those who had not used either cannabis or alcohol, although its role is not necessarily causal because THC stays in the bloodstream for days to weeks after intoxication.[71][72][c]
Hempseed oil is manufactured from varieties of Cannabis sativa that do not contain significant amounts of tetrahydrocannabinol (THC), the psychoactive element present in the cannabis plant. This manufacturing process typically includes cleaning the seed to 99.99% before pressing the oil. There is no THC within the hempseed, although trace amounts of THC may be found in hempseed oil when plant matter adheres to the seed surface during manufacturing. The modern production of hempseed oil, particularly in Canada, has successfully lowered THC values since 1998.[5] Regular accredited sampling of THC in Canadian hemp seed oil shows THC levels usually below detection limit of 4 ppm (parts per million, or 4 mg/kg). Legal limit for THC content in foodstuffs in Canada is 10 ppm.[6] Some European countries have limits of 5 ppm or none-detected, some EU countries do not have such limits at all.
We use cookies and similar technologies to improve your browsing experience, personalize content and offers, show targeted ads, analyze traffic, and better understand you. We may share your information with third-party partners for marketing purposes. To learn more and make choices about data use, visit our Advertising Policy and Privacy Policy. By clicking “Accept and Continue” below, (1) you consent to these activities unless and until you withdraw your consent using our rights request form, and (2) you consent to allow your data to be transferred, processed, and stored in the United States.
While many states have now passed laws legalizing the production of plants bearing Cannabidiol for medicinal use, these laws will take many months if not years to be implemented while the details are ironed out as to whom will produce the plants and products for distribution in each of these states. Many patients and families in the states that have enacted these CBD laws are frustrated that they currently have no way to access CBD, in most cases assuming that Cannabidiol has to be extracted from illicit Marijuana oil. It has also been frustrating for patients and families that still find themselves in states with neither Medical Marijuana programs that provide access to Marijuana oil nor Cannabidiol laws providing access to CBD.
There are a few things that are better about CBD Pain Cream than taking prescriptions. First of all, prescriptions can take a while to kick in. So, if you’re in pain in the morning, it can be almost impossible to get out of bed. On the other hand, CBD Chiro-Cream can work in as little as five minutes’ post-application. † So, you can get on with your day when you use this product. The magic of CBD Pain Cream is that it helps calm your body’s pain receptors. Every single person has an endocannabinoid system (ECS) that is responsible for telling your brain when you’re in pain, anxious, or uncomfortable.
With President Trump signing off on the Agricultural Improvement Act of 2018 (aka the 2018 Farm Bill) last month, the federal government now fully recognizes hemp as a legal agricultural product. But while many reports are claiming that this means that cannabidiol (CBD) is also legal, that’s not quite correct. With a lot of misinformation flying around, and contradictions between state and federal laws, things are admittedly somewhat confusing. Let’s try to sort things out by answering some questions about hemp, CBD, and what has recently changed in federal law.
Medical cannabis, or medical marijuana, can refer to the use of cannabis and its cannabinoids to treat disease or improve symptoms; however, there is no single agreed-upon definition.[38][39] The rigorous scientific study of cannabis as a medicine has been hampered by production restrictions and other federal regulations.[40] There is limited evidence suggesting cannabis can be used to reduce nausea and vomiting during chemotherapy, to improve appetite in people with HIV/AIDS, and to treat chronic pain and muscle spasms.[41][42][43] Its use for other medical applications is insufficient for conclusions about safety or efficacy.
That headache study cites research linking CBD to lower rates of anxiety. (Since anxiety often produces headaches, the authors say, CBD could be a plausible headache remedy if those anti-anxiety benefits are legit.) Grant says he’s looked at the literature on CBD and anxiety, and some of it is enticing. He mentions a Brazilian study, for instance, that found people with a fear of public speaking felt less anxiety and less discomfort about their phobia after taking CBD, compared to those who took a placebo.

Yes! We ship our CBD oil to over 40 countries including Argentina, Austria, Australia, Belgium, Belize, Brazil, Bulgaria, Chile, China, Colombia, Costa Rica, Croatia, Cyprus, Czech Republic, Denmark, England, Estonia, Finland, France, Georgia, Germany, Greece, Guam, Guatemala, Hong Kong, Hungary, Iceland, India, Ireland, Italy, Japan, Latvia, Lithuania, Luxembourg, Mexico, Netherlands, Antilles, Northern Ireland, Norway, Paraguay, Peru, Poland, Portugal, Puerto Rico, Romania, Russia,  Slovenia, South Africa, Sweden, Switzerland, U.S. Virgin Islands, Uruguay, and many others! If you require assistance completing a payment, please contact us.

Yes! when cold turkey no choice pulled off opiates when cancer returned I turned to medical marijuana! Yes I call it what it is because it saved my life in many ways, believe me I never thought could smoke it because anxiety/paranoid but it’s not true! It’s about educating yourself on the strains and different plants! No one plant is made the same. I highly recommend the Indica now it is known to be best for night because it does put you out as well as that pain! I have cut my Xanax in half! Indica is the one that will make you more relaxed and sleepy but talk about pain relief! also helping with sleep and anxiety! Sativa is your uplifting the happy type more to the head type plant, it will deliver some pain relief depending on which Sativa plant – it will deliver but this strain is known for weight loss, helps with depression, however it can on some plants trigger the anxiety people talk about – you would need to get the plant name and look up medical benefits then side effects, there is sites on this. I studied this plant very thorough before I ever began it. I choose the whole plant with THC – I hate it gets demonized, the THC has around 15 medical benefits. It gets demonized because like a opiate you can get mind altered – well the way I see it .. why is it so sinister to feel good when I live in hell of cancer pain. THC is a killer anti inflammatory! It is 1,000 more strong than aspirin and 100 times more strong than hydrocodone as far as anti inflammatory!!! which is essential for cancer and pain as well. Even an FDA-approved trial in 2013 confirmed THC’s effectiveness for pain relief. Individuals experiencing neuropathic pain were given low doses of THC (1.29%) in the form of vaporized cannabis. The results? “A low dose of delta-9-tetrahydrocannabinol provided statistically significant 30% reductions in pain intensity when compared to placebo.”While clinical research continues to be restricted due to cannabis’s regretful status as a !I controlled!!!
Years passed, and more studies rolled out with medically beneficial findings regarding cannabis until 2009 when Steep Hill Laboratory in Oakland, California, tested cannabis samples provided by Harborside Health Center to discover that a handful of cultivars contained more CBD than THC. This discovery kicked other labs into gear. They wanted to study medical cannabis to understand and potentially calibrate their cannabinoid ratios. Soon thereafter, laboratories uncovered CBD-dominant strains boasting 20:1 CBD to THC ratios, which opened up the cannabis market for a panoply of CBD products. 

Yes, under licence from the Department of Health, certain varieties of the hemp plant (Cannabis sativa) are legally grown for a range of uses including for food and feed. The varieties of hemp permitted to be grown in Europe are those listed in the EU’s ‘Common Catalogue of Varieties of Agricultural Plant Species’ and for which the tetrahydrocannabinol (THC) content does not exceed 0.2% (Regulation (EU) No 1307/2013).
Consumers report using CBD for a huge variety of health and wellness reasons, but a lot more research is needed to determine which symptoms and ailments it works best for. Currently, there are more than 40 clinical trials enrolling patients to examine the effectiveness of CBD for a variety of diseases, including substance use disorder, chronic pain, post-traumatic stress disorder (PTSD), depression, schizophrenia, and many others. Most importantly, CBD is incredibly safe, and not addictive. Even young children can tolerate daily doses of up to twenty milligrams (20 mg) per kilogram (1 kg) of body weight (for a 175 pound adult, that’s more than 1,500 mg). The most common side effect of high-dose CBD is sleepiness.
2104 saw very limited growing of domestic Hemp, as new programs were set up and established, but 2015 and 16 saw a sizable increase in production as many hemp farmers in Colorado, Oregon, Kentucky and Tennessee rolled out production under various state hemp programs. Unfair Marijuana laws should not restrict the growth of Hemp in the U.S, which has a long and proud relationship with Hemp, until it was criminalized along with cannabis by definition of the term Marijuana which came to encompass both illicit Marijuana as well as benign Hemp plants under U.S. law.
In June 2014, the New York Assembly passed S7923, which creates legal protections for patients and caregivers and authorizes the state to license and regulate “registered organizations” to cultivate and sell medical cannabis to patients. Patients must obtain a registration identification card after getting written certification from their physician.
Cannabidiol is currently a class B1 controlled drug in New Zealand under the Misuse of Drugs Act. It is also a prescription medicine under the Medicines Act. In 2017 the rules were changed so that anyone wanting to use it could go to the Health Ministry for approval. Prior to this, the only way to obtain a prescription was to seek the personal approval of the Minister of Health.
The term kief refers to the sticky, bulbous crystalline formations on the tip of a gland called a “trichome.” Trichomes are external resin glands packed with the chemicals that give marijuana its flavors and smells, called “terpenes.” They also contain high concentrations of cannabinoids. These chemicals which interact with our body to produce marijuana’s signature effects.
Other “minor phytocannabinoids” in cannabis may also contribute relevant activity (McPartland and Russo 2001). Cannabichromene (CBC) is the third most prevalent cannabinoid in cannabis, and is also anti-inflammatory (Wirth et al 1980), and analgesic, if weaker than THC (Davis and Hatoum 1983). Cannabigerol (CBG) displays sub-micromolar affinity for CB1 and CB2 (Gauson et al 2007). It also exhibits GABA uptake inhibition to a greater extent than THC or CBD (Banerjee et al 1975), suggesting possible utilization as a muscle relaxant in spasticity. Furthermore, CBG has more potent analgesic, anti-erythema and lipooxygenase blocking activity than THC (Evans 1991), mechanisms that merit further investigation. It requires emphasis that drug stains of North American (ElSohly et al 2000; Mehmedic et al 2005), and European (King et al 2005) cannabis display relatively high concentrations of THC, but are virtually lacking in CBD or other phytocannabinoid content.

In a SAFEX study of Phase III double-blind RCT in 160 subjects with various symptoms of MS (Wade et al 2004), 137 patients elected to continue on Sativex after the initial study (Wade et al 2006). Rapid declines were noted in the first twelve weeks in pain VAS (N = 47) with slower sustained improvements for more than one year. During that time, there was no escalation of dose indicating an absence of tolerance to the preparation. Similarly, no withdrawal effects were noted in a subset of patients who voluntarily stopped the medicine abruptly. Upon resumption, benefits resumed at the prior established dosages.


^ Gobbi, Gabriella; Atkin, Tobias; Zytynski, Tomasz; Wang, Shouao; Askari, Sorayya; Boruff, Jill; Ware, Mark; Marmorstein, Naomi; Cipriani, Andrea; Dendukuri, Nandini; Mayo, Nancy (13 February 2019). "Cannabis Use in Adolescence and Risk of Depression, Anxiety, and Suicidality in Young Adulthood". JAMA Psychiatry. doi:10.1001/jamapsychiatry.2018.4500. Retrieved 13 February 2019.
The clinical trials performed with Sativex have recently been assessed in two independent review articles (Barnes 2006; Pérez 2006). In a Phase II clinical trial in 20 patients with neurogenic symptoms (Wade et al 2003), Tetranabinex, Nabidiolex, and Sativex were tested in a double-blind RCT vs placebo (Table 1). Significant improvement was seen with both Tetranabinex and Sativex on pain (especially neuropathic), but post-hoc analysis showed symptom control was best with Sativex (p < 0.0001), with less intoxication than with THC-predominant extract.
Cannabis sales have been illegal since the 1970 Controlled Substances Act was passed, with the only exceptions being the products made from the "mature stalk" and "sterilized seed" of the hemp plant, which could still be sold since they contained little to no psychoactive components. Even today, federal law has not changed its stance on cannabis. On the state level, however, things have changed dramatically. As of this writing, there are 30 states that have legalized the sale of cannabis in some form, whether that be medicinally or recreationally. Because federal law continues to outlaw the production and sales of cannabis aside from the CBD oil and hemp seed oil from hemp plants, it is illegal for states that have legalized cannabis to sell products across state borders.
Adverse effects of cannabinoids on immune function have been observed in experimental animals at doses 50–100 times the psychoactive level (Cabral 2001). In four patients using herbal cannabis therapeutically for over 20 years, no abnormalities were observed in leukocyte, CD4 or CD8 cell counts (Russo et al 2002). Investigation of MS patients on Cannador revealed no major immune changes (Katona et al 2005), and similarly, none occurred with smoked cannabis in a short-term study of HIV patients (Abrams et al 2003). Hematological measures have been normal in all Sativex RCTs without clinical signs of immune dysfunction.
While very few clinical trials have explored the pain-relieving effects of CBD oil, a report published in the Cochrane Database of Systematic Reviews in 2018 examined the use of a variety of cannabis-based medicines and found they might be of some benefit in the treatment of chronic neuropathic pain. A type of pain triggered by damage to the somatosensory system (i.e., the system responsible for processing sensory stimuli), neuropathic pain often occurs in people with conditions like diabetes and multiple sclerosis.
     Marijuana oil has been a hot topic over the last few years as many states pass medical Marijuana programs and more and more reports come filtering out of them regarding the therapeutic potentials offered by various extracts featuring high levels of Cannabinoids such as CBD (Cannabidiol), one of the main active substances contained within Cannabis. Dramatic cases featured on such noteworthy TV shows as the Dr. Sanjay Gupta CNN specials that first brought strains such as Charlotte's Web into the national spotlight have done much to raise public awareness of CBD.

Hemp is a controversial crop in some regions of the world, due to concerns about psychoactive plants in the Cannabis genus. In some regions, cultivation of hemp is banned, although products made from hemp such as oil, hemp garments, and hemp paper may be legal. In other areas, hemp is permitted, but only industrial hemp, and some nations freely permit cultivation of all plants in this genus, assuming that regulation is a more efficient technique for control than outright bans. Wild hemp is also not uncommon in some regions of the world, making it difficult to enforce bans on hemp crops.
Third-party testing: Once a CBD oil is manufactured, CBD oil companies will often submit their products for third-party tests, which are conducted by non-company personnel to ensure the product is safe for public consumption and meets quality standards.CBD oils should always be accompanied with information about third-party tests; best practice is to avoid oils that do not supply these details.
Very few randomized controlled trials (RCTs) have been conducted using smoked cannabis (Campbell et al 2001) despite many anecdotal claims (Grinspoon and Bakalar 1997). One such study documented slight weight gain in HIV/AIDS subjects with no significant immunological sequelae (Abrams et al 2003). A recent brief trial of smoked cannabis (3.56% THC cigarettes 3 times daily) in HIV-associated neuropathy showed positive results on daily pain, hyperalgesia and 30% pain reduction (vs 15% in placebo) in 50 subjects over a treatment course of only 5 days (Abrams et al 2007) (Table 1). This short clinical trial also demonstrated prominent adverse events associated with intoxication. In Canada, 21 subjects with chronic pain sequentially smoked single inhalations of 25 mg of cannabis (0, 2.5, 6.0, 9.5% THC) via a pipe three times a day for 5 days to assess effects on pain (Ware et al 2007) with results the authors termed “modest”: no changes were observed in acute neuropathic pain scores, and a very low number of subjects noted 30% pain relief at the end of the study (Table 1). Even after political and legal considerations, it remains extremely unlikely that crude cannabis could ever be approved by the FDA as a prescription medicine as outlined in the FDA Botanical Guidance document (Food and Drug Administration 2004; Russo 2006b), due to a lack of rigorous standardization of the drug, an absence of Phase III clinical trials, and pulmonary sequelae (bronchial irritation and cough) associated with smoking (Tashkin 2005). Although cannabis vaporizers reduce potentially carcinogenic polyaromatic hydrocarbons, they have not been totally eliminated by this technology (Gieringer et al 2004; Hazekamp et al 2006).

In making the two previous determinations about THC, why did FDA conclude that THC is an active ingredient in a drug product that has been approved under section 505 of the FD&C Act? In making the two previous determinations about CBD, why did FDA determine that substantial clinical investigations have been authorized for and/or instituted, and that the existence of such investigations has been made public?
Did you know that pain is the number one reported condition for medical marijuana cards in the U.S.? In Colorado alone, 92% of patients, over 86,000 people, use cannabis to treat their chronic pain. Research on CBD and pain management has shown great promise and people are increasingly turning to cannabinoid therapy as the harms of opioids garner more attention and scrutiny.
The self-medication hypothesis was not supported in either the van Os or Henquet studies. Both studies found that early psychotic symptoms did not predict an increased risk of using cannabis (as is required by the self-medication hypothesis). The direction of the relationships was from early cannabis use to psychosis. Their negative results have recently been supported by Verdoux et al. (2002), who examined the temporal relationship between cannabis use and psychotic symptoms using an experience sampling method. They asked 79 college students to report on their drug use and experience of psychotic symptoms at randomly selected time points, several times each day over 7 consecutive days. The sample included high cannabis users (n = 41) and an over-representation of students identified as vulnerable to psychosis (n = 16). Verdoux and colleagues found that in time periods when cannabis was used, users reported more unusual perceptions, and these relationships were stronger in vulnerable individuals. There was no temporal relationship between reporting unusual experiences and using cannabis use, as would be predicted by the self-medication hypothesis.

Though unflavored and priced higher than competitors, Green Roads CBD oils are made by a trusted manufacturer and use organically grown hemp. Following the CO2 supercritical fluid extraction process, board-certified pharmacists formulate the tincture by hand. Green Roads only sells CBD isolates, so if you’re looking for broad-spectrum products look to some of our other recommendations.
While all of the long-term effects of marijuana use are not yet known, some research raises serious health concerns. For example, one study examined the health status of 450 daily non-tobacco-smoking marijuana smokers. They found that the marijuana smokers had more sick days and more doctor visits for respiratory and other problems than did a similar group who did not smoke either substance. Regular use of marijuana may play a role in cancer and problems in the respiratory and immune systems. Additionally, research has shown that marijuana use can trigger psychotic symptoms in people who have a genetic vulnerability to schizophrenia.  

     2014 saw a flurry of interest in Cannabidiol in particular, with a slew of states successfully passing CBD only legislation after mounting pressure from many numbers of families with children suffering from intractable Epilepsy resulted in the fast tracking of Cannabidiol laws in more than 10 U.S. states. The Cannabidiol issue is proving to be quite popular politically as it allows politicians to get behind the "won't get you high" side of the CBD story while temporarily dancing around the looming issues of future medical marijuana programs that are pending or have been proposed in many of these states, as well as the national movement towards approval for medicinal and recreational use on a large scale.

Cannabis For Pain

×